Teicoplanin

Description: 
Teicoplanin by immunoassay
Clinical details: 
Teicoplanin (Targocid) is a glycopeptide antibiotic that has bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. Measurement of plasma/serum teicoplanin is useful to optimise parenteral treatment in severe sepsis or burns, deep-seated staphylococcal infection (including bone and joint infection), endocarditis and in intravenous drug abusers.
Related condition or disease: 
Infection
Reference range: 

In bone and joint infections, teicoplanin concentrations should be between 20-40 mg/L, but <60 mg/L. In complicated skin and soft tissue infections, teicoplanin concentrations should be between 15-30 mg/L, but <60 mg/L

Synonyms or keywords: 
Antibiotic, teico, targocid
Units: 
mg/L
Department: 
Toxicology Department
Location: 
King's College Hospital
Sample type and Volume required: 
2mL EDTA whole blood or 1 mL plasma or serum (pre-dose or ‘trough’ sample)
Turnaround time: 
5 working days
Criteria for acceptance / rejections of sample
Storage and transport: 
Please refrigerate (if possible) if not sending immediately. Send by first class post.
Contacts:
Toxicology Department at King's Hospital
020 3299 5881
kch-tr.toxicology@nhs.net
King's College Hospital
Bessemer Wing - 3rd Floor
Denmark Hill
London SE5 9RS
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory: 
Therapeutic Drug Monitoring Laboratory at King's
Teicoplanin request form
PDF (460Kb)

Print as a PDF

Last updated: 10/11/2022